Biochemical and Pharmacological Characterizations of ESI-09 Based EPAC Inhibitors: Defining the ESI-09 “Therapeutic Window”
Yingmin Zhu(The University of Texas Health Science Center at Houston), Xiaodong Cheng(The University of Texas Medical Branch at Galveston)
Cited by 106
Related Papers
A Novel EPAC-Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and Invasion
|Molecular Pharmacology|2012|206
Lithium Inhibits Tumorigenic Potential of PDA Cells through Targeting Hedgehog-GLI Signaling Pathway
|PLoS ONE|2013|43
Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling
|Science Advances|2020|41
Upregulation of Epac1 Promotes Pericyte Loss by Inducing Mitochondrial Fission, Reactive Oxygen Species Production, and Apoptosis
|Investigative Ophthalmology & Visual Science|2023|17
Protein SUMOylation promotes cAMP-independent EPAC1 activation
|Cellular and Molecular Life Sciences|2024|8